Based on SEC filing data. A biotech corporation based in Seattle, WA in the growth stage has raised $91.0M in equity funding. The company is developing biotech solutions and is positioned for expansion.
Get notified the moment ALPINE IMMUNE SCIENCES, INC. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.